Current treatment of nasopharyngeal carcinoma

被引：40

作者：

Chan, Anthony T. C. ^{[1
]}

机构：

[1] Chinese Univ Hong Kong, Hong Kong Canc Inst, Sir YK Pao Ctr Canc, State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China

来源：

EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷

关键词：

BARR-VIRUS DNA; CONCURRENT CISPLATIN-RADIOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; PHASE-II; CHEMOTHERAPY; PLASMA; SURVIVAL; CARBOPLATIN; METASTASIS; DISEASE;

D O I：

10.1016/S0959-8049(11)70179-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：S302 / S303

页数：2

共 23 条

[1]

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099 [J].

Al-Sarraf, M ;

LeBlanc, M ;

Giri, PGS ;

Fu, KK ;

Cooper, J ;

Vuong, T ;

Forastiere, AA ;

Adams, G ;

Sakr, WA ;

Schuller, DE ;

Ensley, JF .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1310-1317

[2]

Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients [J].

Baujat, B ;

Audry, W ;

Bourhis, J ;

Chan, ATC ;

Onat, H ;

Chua, DTT ;

Kwong, DLW ;

al-Sarraf, M ;

Chi, KH ;

Hareyama, M ;

Leung, SF ;

Thephamongkhol, K ;

Pignon, JP .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (01) :47-56

[3]

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].

Chan, A. T. C. ;

Gregoire, V. ;

Lefebvre, J. -L. ;

Licitra, L. ;

Felip, E. .

ANNALS OF ONCOLOGY, 2010, 21 :v187-v189

[4]

Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma [J].

Chan, ATC ;

Leung, SF ;

Ngan, RKC ;

Teo, PML ;

Lau, WH ;

Kwan, WH ;

Hui, EP ;

Yiu, HY ;

Yeo, W ;

Cheung, FY ;

Yu, KH ;

Chiu, KW ;

Chan, DT ;

Mok, TSK ;

Yau, S ;

Yuen, KT ;

Mo, FKF ;

Lai, MMP ;

Ma, BBY ;

Kam, MKM ;

Leung, TWT ;

Johnson, PJ ;

Choi, PHK ;

Zee, BCY .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (07) :536-539

[5]

Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: Therapeutic monitoring with plasma Epstein-Barr virus DNA [J].

Chan, ATC ;

Ma, BBY ;

Lo, D ;

Leung, SF ;

Kwan, WH ;

Hui, EP ;

Mok, TSK ;

Kam, M ;

Chan, LS ;

Chiu, SKW ;

Yu, KH ;

Cheung, KY ;

Lai, K ;

Lai, M ;

Mo, F ;

Yeo, W ;

King, A ;

Johnson, PJ ;

Teo, PML ;

Zee, B .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) :3053-3060

[6]

Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors [J].

Chan, ATC ;

Tao, Q ;

Robertson, KD ;

Flinn, IW ;

Mann, RB ;

Klencke, B ;

Kwan, WH ;

Leung, TWT ;

Johnson, PJ ;

Ambinder, RF .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) :1373-1381

[7]

Chan ATC, 2002, JNCI-J NATL CANCER I, V94, P1614, DOI 10.1093/jnci/94.21.1614

[8]

Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma [J].

Chan, ATC ;

Hsu, MM ;

Goh, BC ;

Hui, EP ;

Liu, TW ;

Millward, MJ ;

Hong, RL ;

Whang-Peng, J ;

Ma, BBY ;

To, KF ;

Mueser, M ;

Amellal, N ;

Lin, X ;

Chang, AY .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3568-3576

[9]

Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma [J].

Cheng, SH ;

Tsai, SYC ;

Yen, KL ;

Jian, JJM ;

Chu, NM ;

Chan, KY ;

Tan, TD ;

Cheng, JC ;

Hsieh, CY ;

Huang, AT .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (10) :2040-2045

[10]

A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients [J].

Chi, KH ;

Chang, YC ;

Guo, WY ;

Leung, MJ ;

Shiau, CY ;

Chen, SY ;

Wang, LW ;

Lai, YL ;

Hsu, MM ;

Lian, SL ;

Chang, CH ;

Liu, TW ;

Chin, YH ;

Yen, SH ;

Perng, CH ;

Chen, KY .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (05) :1238-1244

← 1 2 3 →